Trials / Completed
CompletedNCT02462122
Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 215 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis
Detailed description
A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-118 Lotion | Lotion |
| DRUG | IDP-118 Vehicle Lotion | Lotion |
Timeline
- Start date
- 2015-08-19
- Primary completion
- 2016-11-09
- Completion
- 2016-11-14
- First posted
- 2015-06-03
- Last updated
- 2020-08-20
- Results posted
- 2020-08-20
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02462122. Inclusion in this directory is not an endorsement.